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1 ABSTRACT 24 
Harm reduction has dramatically reduced HIV incidence among people who inject drugs 25 
(PWID). In Glasgow, Scotland, <10 infections/year have been diagnosed among PWID since 26 
the mid-90s. However, in 2015 a sharp rise in diagnoses was noted among PWID: many were 27 
subtype C with two identical drug resistant mutations and some displayed low avidity, 28 
suggesting the infections were linked and recent. 29 
We collected Scottish pol sequences and identified closely related sequences from public 30 
databases. Genetic linkage was ascertained among 228 Scottish, 1820 UK and 524 global 31 
sequences. The outbreak cluster was extracted to estimate epidemic parameters.  32 
All 104 outbreak sequences originated from Scotland and contained E138A and V179E. 33 
Mean genetic distance was <1% and mean time between transmissions was 6.7 months. The 34 
average number of onward transmissions consistently exceeded 1, indicating that spread 35 
was ongoing. 36 
In contrast to other recent HIV outbreaks among PWID, harm reduction services were not 37 
clearly reduced in Scotland. Nonetheless, the high proportion of individuals with a history of 38 
homelessness (45%) suggests that services were inadequate for those in precarious living 39 
situations. The high prevalence of Hepatitis C (>90%) is indicative of sharing of injecting 40 
equipment. 41 
Monitoring the epidemic phylogenetically in real-time may accelerate public health action. 42 
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2  INTRODUCTION 43 
People who inject drugs (PWID) are at risk of acquiring HIV from sharing injecting equipment 44 
and from high risk sexual activity while under the influence of drugs or in exchange for 45 
drugs[1]. There are 9-22 million PWID worldwide of whom 1-5 million have HIV [2]. 46 
Major outbreaks of HIV were identified among PWID in Scotland in the 1980s [3-5], along 47 
with other parts of northern [3, 6], and southern Europe[5]. A major outbreak in Edinburgh 48 
in 1983 associated with extensive needle-sharing [5] led to 50% of PWID becoming infected 49 
[3]. This epidemic was closely linked to similar ones in Dundee and Dublin [3], but few HIV 50 
cases were seen among PWID in Glasgow at the time[7]. Rapid introduction in the UK of 51 
needle exchange in 1986 followed by other harm reduction measures [8], dramatically 52 
decreased spread of HIV within this population. Since the mid-1990s HIV diagnoses among 53 
PWID in Glasgow have averaged 10 per year [9]. Similarly in the rest of Western Europe, 54 
incidence had declined in accordance with public health responses [10]. 55 
However, in 2011 there were reports of outbreaks of HIV among PWID in Greece [11], 56 
Romania [12], and Ireland [13]. Prior to this, HIV incidence among PWID in Greece and 57 
Ireland had been similar to the UK, around 0.1% [2, 14, 15]. In Greece, fewer than 20 58 
infections per year were reported among PWID between 2001 and 2010, but in 2011 this 59 
surged to 256 cases accounting for ¼ of all new HIV diagnoses that year [16]. The epidemics 60 
in Greece [11] and Ireland [13] followed an economic crisis which led to increases in 61 
homelessness. The recession of 2008 resulted in funding cuts to opiate substitution therapy 62 
and needle exchange programs in Greece and Romania [17]. In parallel, the surge in 63 
injection of stimulant-based new psychoactive substances, which are typically injected more 64 
frequently than heroin thus increasing the risk of needle-sharing, contributed to the 65 
outbreaks in Romania [12] and Ireland [13]. 66 
4 
 
In 2015 a significant rise in HIV diagnoses among PWID was noted in Glasgow. Data from 67 
Scotland’s Needle Exchange Surveillance Initiative showed that HIV prevalence among PWID 68 
increased from 0.3% in 2011-12 to 1.9% in 2015-16 [18]. Routine sequencing to test for drug 69 
resistance revealed many were HIV subtype C, a subtype rarely observed among PWID in the 70 
UK [19, 20], suggesting a common source for the outbreak.  71 
Reconstruction of the transmission network through contact tracing is difficult for HIV 72 
because of the time delay between infection and diagnosis, the low transmission rate, and 73 
the challenge of collecting information pertaining to sexual and drug-taking behaviours. 74 
Phylogenetic analysis of viral sequences provides an alternative and independent route to 75 
reconstructing transmission networks [21]. As viral sequences are generated as a 76 
component of routine clinical care in the UK, we conducted a phylogenetic analysis to 77 
investigate whether PWID cases were related, when infections had been acquired, and 78 
whether the strain was spreading into the wider community and elsewhere in the UK. 79 
Results informed the shape and intensity of the public health response. 80 
3 METHODS 81 
3.1 STUDY POPULATION 82 
Since 2005, the West of Scotland specialist virology centre has routinely carried out baseline 83 
sequencing of all new HIV diagnoses. The HIV-1 protease and reverse transcriptase regions 84 
(HXB2 positions 2253 to 3549) were amplified using primers described previously [22] with 85 
Expand reverse transcriptase and the Expand High Fidelity polymerase chain reaction (PCR) 86 
System (Roche) and the following programme: RT-PCR 42oC for 45 min; first round PCR (2 87 
min at 94oC; 10 cycles of 15 sec at 94oC; 30 sec at 55 oC;1 min 30 sec at 72oC; 25 cycles of 15 88 
sec at 94oC; 30 sec at 55oC; 1 min 30 sec at 72oC + 5 sec/cycle; 10 min at 72oC ) and nested 89 
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PCR (2 min at 94oC; 10 cycles of 15 sec at 94oC; 30 sec at 55 oC;1 min 30 sec at 72oC; 25 cycles 90 
of 15 sec at 94oC; 30 sec at 55oC; 1 min 30 sec at 72oC + 5 sec/cycle; 10 min at 72oC). Sanger 91 
sequencing was performed on the ABI3130xl using BigDye Terminator v3.1 Cycle Sequencing 92 
Kit (Applied Biosystems). Alignment and base-calling was performed using the online 93 
sequence analysis software RECall [23]. REGAv3 was used to subtype sequences and detect 94 
drug resistance mutations [24]. All subtype C sequences were extracted from the laboratory 95 
database for further analysis. At each stage (extraction through to PCR) and for each patient, 96 
negative controls were included in each assay to detect contamination. If evidence for 97 
contamination was observed, all patient samples in that run were re-extracted. For each 98 
weekly run a simple phylogenetic tree was constructed to detect contamination occurring at 99 
the sequencing stage. Any cases of sequence identity in the same batch were repeated from 100 
the extraction stage. 101 
Avidity testing was used to classify infections as recent or older than four months. The assay 102 
is a modification of the Genscreen HIV1/2 Version 2 (Bio-Rad) [25] and testing has been 103 
performed on HIV diagnoses since 2012. Clinical and epidemiological information was 104 
obtained through the National Health Service clinical portal, a virtual electronic patient 105 
record that contains clinical notes on interactions with tertiary services and test results. Data 106 
retrieved included hepatitis C status, viral load, date of last HIV negative test, sex, risk group, 107 
age, nationality, and history of drug use, incarceration and homelessness. 108 
3.2 BACKGROUND SEQUENCES 109 
The UK HIV Drug Resistance Database (UKRDB) receives pol sequences obtained for routine 110 
clinical surveillance and submitted by participating laboratories. Resistance data are linked 111 
to demographic and clinical patient data held in the UK Collaborative HIV Cohort study (UK 112 
CHIC) database [26] and the national HIV/AIDS Reporting System (HARS) database held at 113 
Public Health England[27]. After linking sequences to epidemiological data, the data were 114 
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anonymised. In the 2014 release of the database (sequences up to mid-2013), sequences 115 
were available for around 60% of the infected population and >80% of patients diagnosed 116 
since 2005. Of 63,163 sequences in the UKRDB, 15,864 sequences (25.1%) were classified as 117 
subtype C by REGAv3 [24]. Epidemiological data contributed by Public Health England and 118 
Health Protection Scotland included year of birth, gender and self-reported most likely route 119 
of infection (PWID, heterosexual sex, men who have sex with men (MSM), mother to child, 120 
blood product, or unknown). 121 
The Los Alamos National Laboratory (LANL) HIV database compiles all published HIV 122 
sequences, including 11,658 non-UK subtype C pol sequences (accessed 8thAugust 2014). We 123 
used Geneious to BLAST Scottish sequences against UKRDB and LANL sequences, selecting 124 
the ten closest matches for each individual Scottish sequence for analysis [28]. As the same 125 
sequence is hit multiple times, this procedure limits the size of the final alignments. Final 126 
alignments comprised 228 sequences from Scotland, 1820 from the UKRDB and 524 from 127 
LANL (2572 in total). 128 
3.3 GENETIC LINKAGE AND PHYLODYNAMIC ANALYSIS 129 
Sequences were stripped of 44 sites associated with drug resistance based on the 2013 130 
International AIDS Society list [29]. We reconstructed genetic clusters by calculating genetic 131 
distances between pairs of sequences under a TN93 substitution model. Each sequence was 132 
represented in the network by a node and nodes were linked if their pairwise distance was 133 
below a certain genetic distance threshold. At thresholds 1-2.5%, the same PWID outbreak 134 
cluster stood out (n=104, see Results), with all sequences from Scotland. We selected the 135 
tightest threshold because 1% is consistent with recent and rapid transmission [30]. 10% of 136 
outbreak sequences were submitted to Genbank (Accession numbers 137 
MG76186:MG761826). Sequences from the outbreak were further analysed using the 138 
Bayesian birth-death skyline model in BEAST2 [31, 32]. The birth-death skyline is well suited 139 
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to analysing outbreaks, because unlike coalescent models, it does not assume low sample 140 
fraction within an infinite population size; instead, sample fraction is explicitly 141 
parameterized. Furthermore, the birth-death skyline estimates the effective reproductive 142 
number Re, the average number of infections originating from each individual, directly 143 
yielding epidemiologically-relevant results. Substitution models (TN93, GTR+G+I) and clock 144 
models (strict, uncorrelated lognormal) were compared and a GTR+G+I model with an 145 
uncorrelated lognormal clock was selected based on its Bayes factor. Chain samples were 146 
run for 500,000,000 generations in triplicate. Prior distributions for Re and the rate of 147 
becoming non-infectious were extracted from a previous analysis of the UK epidemic[31], 148 
and priors for the origin of the tree and the sampling proportion were based on our 149 
knowledge of the UK epidemic. The origin of the tree was set with a maximum value of 30 150 
years and the sampling proportion was set as 0 until 2005 (the date of the first outbreak 151 
sequence) then with a normal distribution with mean=0.65 and sd=0.05. Because sampling 152 
fraction, Re and time to becoming non-infectious are correlated in the birth-death skyline 153 
model, at least one must be set with a narrow prior [31]. 154 
4 RESULTS 155 
4.1 THE DRUG-RESISTANT SUBTYPE C OUTBREAK HAS NOT BEEN OBSERVED 156 
OUTSIDE SCOTLAND 157 
All Scottish subtype C sequences were included in the phylogenetic analysis (n=228), 158 
alongside 1820 sequences from the UKRDB and 524 from LANL (2572 in total). Of 2572 159 
sequences, 501 (19.5%) linked to at least one other in the network using a genetic distance 160 
cut-off of 1%. 161 
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Within the network, a tight cluster of 104 sequences stood out (Figure 1). All sequences 162 
within the cluster were less than 1% genetic distance from at least one other sequence in 163 
the cluster. Mean genetic distance was <1% with 7 patients with pol sequences exactly 164 
identical to another, 2 pairs and 1 triad. All sequences originated from Scotland and 165 
contained E138A and V179E. Thus we have not yet observed evidence of spread of this 166 
strain outside Scotland. E138A is a common polymorphic accessory mutation weakly 167 
selected in patients receiving etravirine and rilpivirine that reduces susceptibility to these 168 
two antiretrovirals by around two fold. V179E is a non-polymorphic mutation weakly 169 
selected by nevirapine and efavirenz and associated with resistance to nevirapine, efavirenz 170 
and etravarine. In the UKRDB, which includes sequences sampled in Scotland until mid-2013, 171 
E138A is found in 1648/15,864 of subtype C sequences (10.39%) and V179E is found in 50 172 
(0.32%). Only 41 sequences in the UKRDB contained both mutations (0.25%), of which 26 173 
were from the present outbreak. Among the remaining fifteen, twelve sequences comprising 174 
both mutations were not closely related to the outbreak and were not included in the 175 
phylogenetic analysis; and three were included in the analysis but did not link to the 176 
outbreak. Between 2014 and mid-2016, 5 non-outbreak HIV diagnoses were made among 177 
PWID in Scotland. 178 
4.2 SPREAD OF HIV AMONG SCOTTISH PWID HAS BEEN RECENT AND RAPID 179 
Sequences from the outbreak cluster (n=104) were selected for analysis using the birth-180 
death skyline models in BEAST2 to estimate growth through time and to better infer the 181 
origin of the cluster. Runs converged within 5,000,000 generations with ESS values above 182 
200. 183 
The common ancestor to the cluster was dated as mid-2003 (2003.4; 95%HPD: 2001.8-184 
2005.0), while the oldest outbreak sequence was from a female PWID diagnosed in 2005. 185 
Five patients were diagnosed in 2008-2009 (4.8%), 27 were diagnosed between 2010 and 186 
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2013 (26.0%) and 71 patients were diagnosed after 2014 (68.3%). All were diagnosed in 187 
Scotland and all those with a risk group reported were PWID.  188 
The birth death skyline infers the effective reproductive number Re (the average number of 189 
transmissions for each individual). Importantly, Re has remained above 1 throughout the 190 
course of the outbreak (Figure 2), implying that the number of cases would be expected to 191 
continue to rise. Mean Re was estimated as 1.5 (95%HPD 0.1-3.9) over the course of the 192 
outbreak, rising to 1.8 (HPD 1.1-2.6) during the last 2 years. At its highest point, in 2009, Re 193 
exceeded 2. Sample fraction was estimated as 0.66 (HPD 0.46 -0.81). 194 
The distance between internal nodes in the tree approximates the upper bound on time 195 
between transmission events [33]. Based on the time-resolved trees, the average 196 
transmission interval was estimated as 6.7 months for the outbreak as a whole 197 
(Supplementary Information). Looking at the phylogeny in more detail, it divided into three 198 
subclusters: 1a, 1b, and 2, originating in peak2 and 2010, respectively (Figure 3). Subclusters 199 
1a and 1b had a higher density of recent transmission events, but there was no difference in 200 
transmission intervals between subclusters based on an analysis of 1,000 trees from the 201 
posterior distribution (Supplementary Information), indicating that while subclusters 1a and 202 
1b are most active at present, the transmission dynamics within all three subclusters have 203 
been similar. The origin of subclusters 1a and 1b correlated with an increase in Re (Figure 2). 204 
4.3 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF OUTBREAK MEMBERS  205 
Among the 104 individuals in the outbreak diagnosed by mid-2016, 102 (98.1%) reported 206 
injecting drugs. Mean age was 38.4 (SD=6.5), 63/103 (61.2%) were men and 40 (38.8%) were 207 
women, 99/100 were white British (1 mixed race), 38/96 (39.6%) had a recorded history of 208 
incarceration and 41/92 (44.6%) reported having ever been homeless. 96/98 (98.0%) were 209 
confirmed to be HCV antibody positive, with 6 not tested, suggesting wide-spread sharing of 210 
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injecting equipment. 68/96 (70.8%) had ongoing HCV infection with a positive HCV antigen 211 
or PCR result. 212 
HIV avidity was tested on 87/104 (83.7%) patients and 49/104 has a previous negative test 213 
result. 24/87 (27.6%) had low avidity results indicating that infection had occurred within 214 
the last four months. Five additional patients had a date of last negative HIV test less than a 215 
year previous to their diagnosis. Three patients had antibody levels too low for avidity 216 
testing indicating acute seroconversion, confirmed with negative Western Blot and BiSpot 217 
results. Therefore, in total at least 32/87 (36.8%) had HIV for less than a year at diagnosis, 218 
consistent with the short terminal branch lengths in the phylogenetic tree (Figure 3).  219 
5 DISCUSSION 220 
This recent outbreak in Scotland is the latest in a series of rapid transmissions of HIV among 221 
PWID; in Greece [11], Romania [12], Ireland [13] and Indiana, USA [34]. Prior to these 222 
outbreaks, HIV incidence among PWID in these regions had been fairly static since the 223 
epidemics of the 1980s. From 2001 to 2014 there were 10-20 new cases per year in Scotland 224 
with 5-10 new cases around Glasgow [35]. The Scottish outbreak now comprises over one 225 
hundred linked cases.  226 
Phylodynamic analysis demonstrated how rapidly the virus was transmitted, with average 227 
transmission intervals around 6 months, similar to MSM [33] and shorter than heterosexuals 228 
[36] in the UK. In contrast to the more commonly presented R0, which represents the 229 
number of onward transmissions in a fully susceptible population, Re is the number of 230 
secondary infections for the current frequency of susceptibles [37]. The number of 231 
secondary infections has averaged 1.5 since the outbreak originated around 2003, reaching 232 
2 at its peak in 2009. In contrast, HIV diagnoses among PWID did not reach a peak until 2015 233 
in Scotland remained around 20 per year between 2008 and 2010, not reaching a peak until 234 
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2015[38]. UK estimates of Re for heterosexuals and MSM are below 1, and just above 1, 235 
respectively [39]. Previous estimates of Re among PWID have ranged as high as 21.7 in 236 
Lithuania [40]. For the UK, estimates of Re do not exist for PWID, but Re was consistently 237 
above 1 for this outbreak, indicating that spread was ongoing in 2016. This number is 238 
specific to this outbreak and should not be extrapolated to reflect HIV transmission among 239 
PWID in the UK in general. The outbreak subdivided into subclusters, indicating independent 240 
concurrent transmission chains. All three transmission chains showed evidence of recent 241 
transmission events, and had equally short transmission intervals.  242 
Genetic distance within the outbreak was extremely low, with multiple sets of identical 243 
partial pol sequences, a phenomenon observed in cases of rapid transmission [41]. While in 244 
part due to the short region of the virus sequenced, such low divergence demonstrates how 245 
rapidly the virus spread in this group. The potential for multiple partners during acute 246 
infection leads to low genetic diversity within PWID transmission networks. The recent 247 
outbreak among Greek PWID similarly displayed low diversity and high clustering[11], 248 
reminiscent of the spread of near identical subtype A variants throughout Eastern European 249 
and Russian PWID in the 1990s [42]. Full genome sequencing, currently being undertaken, 250 
may disentangle the sequence of transmissions within the outbreak. 251 
The outbreak was in part detected because of two resistance mutations, E138A and V179E, 252 
repeatedly identified in subtype C viruses, which had not previously associated with PWID 253 
infection in the UK. This prompted a search through the UKRDB for the mutations and for 254 
related sequences. At present, despite the UKRDB collecting sequences from all HIV 255 
resistance tests, sequences are used for research purposes and not as a systematic 256 
surveillance tool. Genetic analysis confirmed the strain was unique to Scotland and is not 257 
transmitting elsewhere in the UK. In the UK it is rare to find large clusters from a single 258 
region [43], and this is now the largest cluster of HIV among PWID seen in the UK since the 259 
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1980s. However, we did not have samples from the rest of the UK as recent as those from 260 
Scotland. The most recent Scottish sequence was sampled in 2016, whereas the most recent 261 
UKRDB sequence was sampled in 2013. It is possible that the outbreak has spread outside 262 
Scotland but that we have not captured it. 263 
No published PWID outbreaks have reported transmission of resistance mutations, although 264 
preliminary results from Saskatchewan, Canada, demonstrated the G190 mutation 265 
disproportionately affected Aboriginal PWID[44]. Earlier studies found a higher prevalence 266 
of resistance mutations among PWID than among those infected sexually[45]. Suboptimal 267 
treatment adherence among this group may provide an explanation for this 268 
phenomenon[46]. Another possibility is that blood to blood transmission could enable 269 
transmission of lower fitness viruses unable to establish infection through sexual 270 
transmission[47]. 271 
Despite access to injecting equipment, HIV still poses a significant risk to PWID. The 272 
identification of a unique strain facilitated its detection in Scotland during this outbreak, but 273 
real-time monitoring may help accelerate public health action. British Columbia recently 274 
deployed a real-time phylogeny response, where monthly reports were generated detailing 275 
cluster growth[48]. This analysis revealed a highly active cluster that expanded by eleven 276 
cases in three months. Members of the cluster were contacted to ensure linkage to care and 277 
partner notification and subsequently no further cases linked to those members were 278 
diagnosed. In the case of the Scottish outbreak, real-time phylogenetic monitoring could 279 
have brought the cluster to attention sooner. At present all UKRDB analyses are conducted 280 
with anonymised data, while Poon et al identified subjects to reach out to them. Use of non-281 
anonymised HIV data for phylogenetic analyses is avoided in some jurisdictions because of 282 
the criminalisation of HIV transmission. An anonymised version of Poon’s system can also be 283 
imagined, in which the background of sequences for comparison is anonymous but data are 284 
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available for the patient being seen at that moment [49]. If the patient’s sequence were to 285 
cluster with two or more recent sequences, that patient could be selected for early initiation 286 
of treatment and pre-exposure prophylaxis could be offered to their partners. The 287 
advantage of Poon’s method is that all members of the cluster can be retrospectively 288 
contacted whereas under the anonymised system, only patients diagnosed after the first 289 
few in a cluster would be identified. Overall, advances such as avidity testing and real-time 290 
phylogenetic analysis can be used to improve our understanding of outbreaks to better 291 
target public health responses. 292 
Many PWID involved in the outbreak had experienced homelessness. Scotland’s Needle 293 
Exchange Surveillance Initiative emphasised this point: almost 90% (20/23) of PWID from 294 
Glasgow who tested positive for HIV in 2015-16 had a history of homelessness, three-295 
quarters of whom had been homeless within the last 6-months [18]. The situation in 296 
Scotland differs from that in other PWID outbreaks, however, because harm reduction 297 
services (Injecting Equipment Provision, Opiate Substitution Therapy) were available in 298 
Scotland post-recession. Indeed, Glasgow operates one of the most active Injecting 299 
Equipment Provision service in Europe, distributing over one million syringes per year[18]. In 300 
contrast, in Indiana, neither needle exchange nor HIV testing were available at the time of 301 
the outbreak[34]. Nonetheless, the association observed with homelessness suggests that 302 
harm reduction services available in Glasgow may have been difficult to access for those in 303 
precarious living situations, often with chaotic lifestyles.  304 
This outbreak may have been due to a change in circumstances, but it may result from the 305 
unfortunate introduction of HIV into a group of connected but previously uninfected PWID, 306 
such as was the case in Sweden in 2006 [50] and in Indiana in 2015 [34]. The high prevalence 307 
of hepatitis C among PWID in this outbreak (>90%) is indicative of widespread injecting 308 
equipment sharing. In contrast, in Romania and Greece, multiple strains and networks were 309 
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uncovered [11, 12]; these outbreaks resulted from the reduced availability of harm 310 
reduction services. The Scottish outbreak is being managed through education of the 311 
population at risk and service providers, improved addiction services, increasing provision of 312 
needle exchange (e.g. greater evening availability), improving accessibility of HIV testing, and 313 
outreach services to support early treatment and retention. Further research is needed to 314 
demonstrate whether homelessness, or other behavioural factors, played a role in the 315 
outbreak. 316 
6 FIGURES 317 
 318 
Figure 1: Genetic distance network of relatedness at 1%. Of 2572 sequences analysed, only 319 
those linked to at least one other sequence at 1% are shown (501 in total). Sequences are 320 
coloured by origin: Scotland, the UK HIV Drug Resistance Database (UKRDB) or Los Alamos 321 
National Database (LANL). Node shapes are determined by drug susceptibility of viruses. 322 
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One large cluster, highlighted and circled, stood out due to its size (104 sequences), its 323 
concentration of drug-resistant sequences and its Scottish origin. 324 
 325 
Figure 2. Reproductive number Re inferred from the birth death skyline plot. The line across 326 
the plot marks Re=1, the threshold above which an infection will continue to spread. 327 
 328 
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 329 
Figure 3: Time-resolved phylogeny for the outbreak cluster comprising 104 sequences from 330 
Scotland with drug resistant mutations E138A and V179E. The outbreak subdivided into 331 
three subclusters.  332 
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